companydata.dkGemCap Biotech ApS: Financial statements 2023
CVR: 38189174
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000. The solvency ratio was 100%.
- Profit/Loss
- 0 kr.
- Equity
- 27,000 kr.
- Total Assets
- 27,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 0 | 27 t. | 0 |
| 2022 | - | - | 0 | 27 t. | - |
| 2021 | - | - | 0 | 7 t. | - |
| 2020 | - | - | 0 | 7 t. | - |
| 2019 | - | - | 0 | 7 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GemCap Biotech ApS has published its annual report for 2022. The net result was DKK 0.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016 and dissolved in 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000.